
Salvia divinorum is a psychoactive plant in the mint family (Lamiaceae) native to the cloud forests of the Sierra Mazateca in Oaxaca, Mexico, where it has been used for centuries by the Mazatec people in healing and divination ceremonies under the name**"ska Maria Pastora"** (leaves of Mary the Shepherdess). It stands apart from virtually every other hallucinogenic substance in both mechanism and character: its active compound,Salvinorin A, is the most potent naturally occurring hallucinogen by weight, producing profound dissociative and visionary states at doses as low as200--500 micrograms when smoked .
What makes Salvia divinorum pharmacologically unique is that it achieves these effects through an entirely non-serotonergic mechanism. While classical psychedelics (LSD, psilocybin, DMT) and even atypical hallucinogens like ibogaine all engage the serotonin system, Salvinorin A is ahighly selective kappa-opioid receptor (KOR) agonist that shows no significant affinity for the 5-HT2A receptor or any other serotonin receptor subtype . It was also the first known naturally occurring kappa-opioid agonist with anon-nitrogenous (terpenoid) structure --- a remarkable finding because virtually all previously known opioid receptor ligands contained a nitrogen atom, which was considered essential for opioid receptor binding.
The subjective experience is equally distinctive. Rather than the gradual onset, visual geometry, and expanded consciousness typical of serotonergic psychedelics, smoked Salvia produces a rapid, intense, and often disorienting experience: users report being pulled into entirely alternate realities, experiencing gravitational distortions, perceiving themselves as inanimate objects, encountering entity-like presences, and losing all sense of personal identity --- effects lasting only5--10 minutes when smoked but often described as profoundly bizarre and sometimes unsettling. The traditional Mazatec method of chewing fresh leaves produces a gentler, longer experience more conducive to introspection .
References
Siebert DJ. Salvia divinorum and salvinorin A: new pharmacologic findings. J Ethnopharmacol. 1994;43(1):53-56. Roth BL, et al. Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proc Natl Acad Sci USA. 2002;99(18):11934-11939. Valdes LJ, et al. Ethnopharmacology of ska Maria Pastora (Salvia divinorum, Epling & Jativa-M). J Ethnopharmacol. 1983;7(3):287-312.
Safety at a Glance
High Risk- Physical Environment
- Route of Administration
- Toxicity: Physical Toxicity Salvia divinorum demonstrates remarkably low physical toxicity. No lethal dose has been established...
- Overdose risk: No fatal overdoses from Salvia divinorum or Salvinorin A have been documented in the medical lite...
If someone is in crisis, call 911 or Poison Control: 1-800-222-1222
Dosage
Smoked
Sublingual
Duration
Smoked
Total: 15 hrs – 30 hrsSublingual
Total: 60 hrs – 120 hrsHow It Feels
The pipe is in your hands. You take a deep breath of the dense, slightly acrid smoke and hold it. For a few seconds nothing happens — and then reality begins to slide sideways.
It starts at the edges: a pulling sensation, as though gravity has suddenly decided to operate at a ninety-degree angle to its usual direction. The room begins to stretch and distort. You become aware that you are laughing — hard, uncontrollably — though nothing is funny. The laughter feels mechanical, as if something else is laughing through you.
Within thirty seconds of exhaling, the room is gone. Not dimmed, not distorted — simply absent. In its place is something else entirely. You are no longer a person sitting on a couch. You are part of the couch. Or you are a page in an enormous book that is being turned by vast, indifferent hands. Or you are one segment of an infinite conveyor belt, and every segment is a different moment of your life, and you have always been this, and the idea that you were ever a human being was a brief and incomprehensible dream.
There is a presence — or multiple presences. They are not hostile, but they are not friendly either. They are simply there, the way the walls of a room are there. They seem to be showing you something, or pulling you somewhere, with absolute authority. You have no capacity to resist because you have no capacity for anything. The concept of "you" has become meaningless. The concept of "concept" has become meaningless.
Time has stopped or is moving in a direction that has nothing to do with forward. You may relive a moment from childhood with absolute conviction that you are five years old and the last twenty years never happened. Or you may find yourself in a place that has no analogue in waking experience — a space made of pure geometry, or a landscape of living color that extends in directions you have no words for.
The physical world reassembles itself in pieces, like a puzzle being solved from the outside in. First the edges of objects, then their solidity, then the sense that you have a body, then the memory of who you are. The whole peak has lasted perhaps five to ten minutes, but it feels as though you have been gone for a very long time. You are sitting on the couch. The room is the room again. You are intensely relieved, and also bewildered, and there is a residual strangeness clinging to everything — a sense that the ordinary world is somehow thinner than it was before, that it is sitting on top of something else.
Over the next twenty to thirty minutes, the strangeness fades. You feel normal again, though perhaps quieter and more contemplative than before. There is no hangover, no stimulation, no residual visual disturbance. But the memory of what happened — the sensation of being peeled apart, of becoming an object, of the presences — stays sharp and clear and deeply strange, sometimes for years.
Subjective Effects
The effects listed below are based on the Subjective Effect Index (SEI), an open research literature based on anecdotal reports and personal analyses. They should be viewed with a healthy degree of skepticism. These effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects.
Physical Effects
Physical(6)
- Changes in felt gravity— A distortion of one's proprioceptive sense of gravity in which the perceived direction of gravitatio...
- Laughter fits— Spontaneous, uncontrollable, and often prolonged episodes of intense laughter that erupt without any...
- Motor control loss— A distinct decrease in the ability to control one's physical body with precision, balance, and coord...
- Respiratory depression— A dangerous slowing and shallowing of breathing that can progress from barely noticeable reductions ...
- Sedation— A state of deep physical and mental calming that manifests as a progressive desire to remain still, ...
- Stimulation— A state of heightened physical and mental energy characterized by increased wakefulness, elevated mo...
Cognitive & Perceptual Effects
Visual(3)
- Drifting— The visual experience of perceiving stationary objects, textures, and surfaces as appearing to flow,...
- Geometry— The experience of perceiving complex, ever-shifting geometric patterns superimposed over the visual ...
- Internal hallucination— Vivid, detailed visual experiences perceived within an imagined mental landscape that can only be se...
Cognitive(9)
- Amnesia— A complete or partial inability to form new memories or recall existing ones during and after substa...
- Anxiety— Intense feelings of apprehension, worry, and dread that can range from a subtle background unease to...
- Cognitive dysphoria— A cognitive and emotional state of intense dissatisfaction, discomfort, and malaise encompassing fee...
- Confusion— An impairment of abstract thinking marked by a persistent inability to grasp or comprehend concepts ...
- Depersonalization— A detachment from one's own sense of self, body, or mental processes, as if observing oneself from o...
- Depression— A persistent state of low mood, emotional numbness, hopelessness, and diminished interest or pleasur...
- Derealization— A perceptual disturbance in which the external world feels profoundly unreal, dreamlike, or artifici...
- Psychosis— Psychosis is a serious psychiatric state involving a fundamental break from consensus reality — char...
- Time distortion— Subjective perception of time becomes dramatically altered — minutes may feel like hours, or hours p...
Transpersonal(1)
- Entity contact— Perception of encountering autonomous beings or presences during psychedelic states, ranging from va...
Pharmacology
Mechanism of Action
Salvinorin A, the principal psychoactive compound in Salvia divinorum, operates through a mechanism that is fundamentally distinct from all other known psychedelics. It is a highly selective and potent full agonist at the kappa-opioid receptor (KOR), with a Ki value of approximately 1.0 nM. Critically, Salvinorin A has no significant affinity for the serotonin 5-HT2A receptor — the target responsible for the effects of classical psychedelics such as LSD, psilocybin, and DMT — nor does it interact meaningfully with dopamine, norepinephrine, GABA, glutamate, or muscarinic receptors at pharmacologically relevant concentrations. This makes it the first known non-nitrogenous, non-alkaloid psychoactive compound that produces profound alterations in consciousness.
Kappa-Opioid System
The kappa-opioid receptor system modulates perception, mood, and consciousness in ways that are largely antagonistic to the mu-opioid (euphoric) system. KOR activation produces dysphoria, perceptual distortion, dissociation, and sedation. This accounts for the characteristically challenging and often dysphoric quality of the Salvia experience, which contrasts sharply with the frequently euphoric or mystical character of serotonergic psychedelics. KOR agonism also modulates dopamine release in the nucleus accumbens (reducing it), which may explain the lack of reinforcing properties and the absence of addictive potential.
Pharmacokinetics
When smoked or vaporized, Salvinorin A is rapidly absorbed through the pulmonary alveoli, reaching the brain within seconds. Peak plasma levels are achieved within 2 minutes, and the compound is rapidly metabolized and cleared, with a plasma half-life estimated at approximately 8 minutes. Hepatic metabolism converts Salvinorin A primarily to Salvinorin B (an inactive deacetylated metabolite) via carboxylesterases. The extremely rapid onset and short duration of smoked Salvia is a direct consequence of this pharmacokinetic profile. When administered sublingually via chewed leaf quids, absorption is slower and less efficient, producing a more gradual onset (10-20 minutes), lower peak intensity, and longer total duration (60-120 minutes). Bioavailability is estimated at roughly 50% via inhalation and 10-25% sublingually.
Endogenous Kappa System
The kappa-opioid system is involved in stress response, pain modulation, and mood regulation. Dynorphin, the endogenous ligand for KOR, is released during stress and is implicated in the dysphoric components of the stress response. Salvinorin A's potent activation of this system essentially triggers a pharmacological stress-dissociation state, which may account for the commonly reported feelings of unease, strangeness, and loss of self.
Detection Methods
Salvinorin A is not detected by any standard drug screening panel. It is not included in typical 5-panel, 10-panel, or extended workplace or military drug tests. The compound is structurally unrelated to all other commonly screened substances (opioids, amphetamines, cannabinoids, benzodiazepines, cocaine metabolites) and produces no cross-reactivity with immunoassay-based screens.
Specialized detection is possible using gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-tandem mass spectrometry (LC-MS/MS), which can identify Salvinorin A and its primary metabolite Salvinorin B in biological specimens. However, the detection window is extremely short due to the compound's rapid metabolism and clearance: Salvinorin A is detectable in blood for only approximately 1 to 2 hours after use, and urinary detection has not been reliably established beyond a few hours. Hair testing for Salvinorin A has not been validated.
In practice, testing for Salvinorin A is essentially never performed outside of research settings or forensic investigations specifically targeting Salvia divinorum use. No commercial laboratory routinely offers Salvinorin A screening as part of standard or extended drug testing services.
Interactions
No documented interactions.
History
Mazatec Traditional Use
The Mazatec people of the Sierra Mazateca in Oaxaca, Mexico have used Salvia divinorum in healing and divinatory rituals for centuries, possibly much longer. The plant is known by several names in Mazatec tradition, most commonly**"ska Maria Pastora"** (leaves of Mary the Shepherdess) --- names that reflect its post-contact syncretism with Catholic imagery. Mazatec curanderos (healers) traditionally administer the fresh leaves bychewing and holding them in the mouth, allowing the active compounds to absorb through the oral mucosa. This method produces a gradual, longer-lasting experience considered more suitable for spiritual and healing work than the intense, brief effects of smoking .
Western Discovery
The first recorded Western observation of the plant's use came from Jean Basset Johnson in1939, during ethnographic fieldwork on hallucinogenic mushroom use among the Mazatec. Johnson documented that the Mazatecs used the leaves of a plant they called "Hierba Maria" to induce visions, though he did not collect botanical specimens and the plant's identity remained uncertain for over two decades .
The pivotal botanical collection came in 1962, when ethnomycologistR. Gordon Wasson and chemistAlbert Hofmann undertook an expedition to Oaxaca specifically to investigate this mysterious plant. Wasson collected flowering specimens that enabled formal botanical classification, and the plant was described as Salvia divinorum by Carl Epling and Carlos Jativa in 1962 . Wasson himself experienced the plant's effects and wrote about its visionary properties.
Chemical Identification of Salvinorin A
The active compound eluded researchers for years. In 1982,Alfredo Ortega and colleagues at the National Autonomous University of Mexico (UNAM) isolated a diterpene they namedSalvinorin A from the plant, determining its chemical structure through spectroscopic analysis . In1984,Leander Valdes III independently isolated and characterized the same compound (initially calling it "divinorin A"), contributing additional pharmacological observations .
The Kappa-Opioid Breakthrough (2002)
For two decades after its isolation, Salvinorin A's mechanism of action remained unknown --- it was clearly hallucinogenic but did not interact with any of the serotonin receptors responsible for classical psychedelic effects. The mystery was solved in 2002 whenBryan Roth and colleagues at Case Western Reserve University demonstrated that Salvinorin A is apotent and highly selective kappa-opioid receptor (KOR) agonist with no significant activity at over 50 other receptor targets tested, including all serotonin receptor subtypes . This was a groundbreaking discovery on multiple levels: it revealed an entirely novel mechanism for naturally occurring hallucinogenic activity, and Salvinorin A was the first non-nitrogenous KOR agonist ever identified --- overturning a long-held assumption that a nitrogen atom was required for opioid receptor binding.
YouTube Era and Legal Response
Salvia divinorum experienced a surge of mainstream awareness in the mid-to-late 2000s, driven largely by viral YouTube videos of people smoking concentrated Salvia extracts and reacting dramatically to the intense, disorienting effects. This media attention prompted a wave ofstate-level legislative action in the United States, with over 20 states passing laws restricting or banning the plant between 2005 and 2015. Internationally, several countries including Australia, Italy, and Denmark enacted bans during the same period. However, Salvia divinorum remains unscheduled at the U.S. federal level and is not controlled under the UN Convention on Psychotropic Substances .
References
Valdes LJ, et al. Ethnopharmacology of ska Maria Pastora (Salvia divinorum, Epling & Jativa-M). J Ethnopharmacol. 1983;7(3):287-312. Johnson JB. The elements of Mazatec witchcraft. Etnologiska Studier. 1939;9:119-149. Epling C, Jativa CD. A new species of Salvia from Mexico. Botanical Museum Leaflets, Harvard University. 1962;20(3):75-76. Ortega A, et al. Salvinorin, a new trans-neoclerodane diterpene from Salvia divinorum. J Chem Soc, Perkin Trans 1. 1982:2505-2508. Roth BL, et al. Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proc Natl Acad Sci USA. 2002;99(18):11934-11939. Siebert DJ. Salvia divinorum and salvinorin A: new pharmacologic findings. J Ethnopharmacol. 1994;43(1):53-56.
Harm Reduction
Use a Sitter
This is the single most important harm reduction measure for Salvia divinorum. The rapid onset of complete dissociation when smoked means the user can lose all awareness of their body and surroundings within seconds. A sober, trusted sitter should be present at all times, prepared to gently prevent the user from standing, walking, or interacting with dangerous objects. The sitter should remain calm, speak minimally, and avoid touching the user unless necessary for safety.
Physical Environment
Use in a safe, controlled environment. Sit or lie down before smoking — never stand. Remove sharp objects, breakable items, open flames, and anything that could cause injury from the immediate area. Close windows and lock doors to the outside. A dark or dimly lit, quiet room is ideal, as bright lights and loud sounds can intensify disorientation and anxiety.
Dosage
Start with plain, unenhanced leaf rather than concentrated extracts (5x, 10x, 20x, etc.). Extracts dramatically increase the intensity and unpredictability of the experience and are responsible for the majority of negative reports. If using extracts, begin with a very small amount — a single small pinch — and increase cautiously in subsequent sessions separated by days. Use a precision scale if working with Salvinorin A isolate.
Route of Administration
Smoking produces the most rapid and intense effects but also the shortest duration. Sublingual administration via chewed leaf quids produces a gentler, longer experience that many users find more manageable and meaningful. The sublingual route is strongly recommended for first-time users.
Timing and Integration
The acute experience lasts only 5 to 15 minutes when smoked, but disorientation and residual effects can persist for 30 to 60 minutes. Do not drive, operate machinery, or make important decisions for at least one hour after use. Allow time for reflection and integration afterward. The experience can be profoundly disorienting and may require processing.
Contraindications
Avoid use if you have a personal or family history of psychosis, dissociative disorders, or severe anxiety. Do not combine with alcohol or other CNS depressants, as this may increase the risk of falls and respiratory complications. Salvia is not known to have dangerous pharmacological interactions, but combining it with other psychoactive substances increases unpredictability.
Toxicity & Safety
Physical Toxicity
Salvia divinorum demonstrates remarkably low physical toxicity. No lethal dose has been established in humans, and no fatalities directly attributable to the pharmacological effects of Salvinorin A have been documented. Animal studies have failed to identify a lethal dose at any practical level of administration. Salvinorin A does not produce significant cardiovascular stimulation, respiratory depression, or organ toxicity at doses far exceeding those used recreationally. The compound is not genotoxic, and no carcinogenic potential has been identified.
Psychological and Behavioral Risks
The primary risks associated with Salvia divinorum are psychological and behavioral rather than physiological. The extremely rapid onset of intense dissociation and hallucination when smoked creates a window of several minutes during which the user may be completely unaware of their physical surroundings and body. This can lead to falls, collisions with objects, walking into traffic, or other accidental injuries. There have been rare but documented cases of individuals running, standing, or moving unpredictably while under the influence. Panic reactions, extreme confusion, and severe dysphoria are common, particularly at higher doses or when the user is unprepared.
Long-Term Considerations
No evidence of neurotoxicity from Salvia divinorum use has been established. The compound does not appear to produce lasting cognitive deficits, nor does chronic use lead to physical dependence or withdrawal symptoms. HPPD (Hallucinogen Persisting Perception Disorder) has not been convincingly linked to Salvia use. Psychological distress following a single intense experience can persist for hours to days in some individuals but typically resolves without intervention.
Addiction Potential
Not habit-forming; most users do not seek to repeat the experience frequently
Overdose Information
No fatal overdoses from Salvia divinorum or Salvinorin A have been documented in the medical literature. The compound's extremely low physical toxicity, absence of respiratory depression, minimal cardiovascular effects, and very short duration of action make pharmacological overdose in the traditional sense essentially impossible at any realistic dose.
The primary acute risk is psychological overwhelm: at high doses, particularly with concentrated extracts, users may experience intense terror, complete dissociation from reality, and total loss of motor control. This can lead to injuries from falls, collisions with objects, or attempts to flee an indoor space.
Management of acute Salvia intoxication:
- Ensure the person is in a safe physical position (sitting or lying down) and cannot injure themselves
- Remove any dangerous objects from reach
- Speak calmly and minimally — do not attempt to restrain or argue
- The acute peak will resolve within 5 to 15 minutes when smoked; simply waiting is usually sufficient
- If persistent agitation or panic occurs beyond 30 minutes, a low-dose benzodiazepine (e.g., diazepam 5-10 mg) may be appropriate
- No specific antidote exists; the kappa-opioid antagonist norbinaltorphimine (nor-BNI) reverses effects in animal models but is not available clinically
- Seek emergency medical attention if the person has sustained a physical injury or exhibits signs of prolonged psychosis
Tolerance
| Full | Rapid but short-lived |
| Half | 1-2 days |
| Zero | 3-5 days |
Cross-tolerances
Legal Status
Salvia divinorum occupies an unusual legal position globally. Despite being one of the most potent naturally occurring psychoactive substances, it remains unscheduled at the federal level in several major countries, including the United States. Its legal status varies dramatically between jurisdictions.
- United States: Not scheduled under the federal Controlled Substances Act, making it one of the few potent hallucinogenic substances with no federal prohibition. Multiple attempts to schedule salvinorin A at the federal level have been introduced in Congress but have not passed. However, individual states have enacted their own laws: Delaware, Florida, Illinois, Kansas, Kentucky, Mississippi, Missouri, North Dakota, Ohio, Oklahoma, South Dakota, and Virginia have prohibited possession and/or sale outright. Several other states restrict sale to minors only (e.g., California, Maine, Maryland). The patchwork of state laws creates a confusing legal landscape.
- Australia: Schedule 9 (Prohibited Substance) under the Poisons Standard since 2002. Australia was one of the first countries to formally prohibit the substance.
- United Kingdom: Not specifically named in the Misuse of Drugs Act, but effectively banned under the Psychoactive Substances Act 2016. Simple possession is not an offense under this Act, but supply carries up to 7 years imprisonment.
- Canada: Not specifically listed as a controlled substance under the CDSA. It remains legal to possess and sell, though it is not approved as a therapeutic product.
- Germany: Not specifically listed under the BtMG (Narcotics Act), but potentially covered by the NpSG (New Psychoactive Substances Act) enacted in 2016. The legal status remains somewhat ambiguous.
- Italy: Classified as a controlled substance since 2005.
- Belgium: Controlled since 2006. Sale and possession are prohibited.
- Denmark: Controlled as a medicinal product since 2003.
- Sweden: Classified as a health hazard substance since 2006, effectively prohibiting sale and import.
- Japan: Designated as a controlled substance since 2007.
- South Korea: Classified as a psychotropic substance. Possession and sale are illegal.
Experience Reports (3)
Tips (5)
Salvia divinorum causes complete loss of motor control and awareness at breakthrough doses. You MUST have a sitter present. Users have walked into traffic, fallen down stairs, and broken glass while fully dissociated.
Standard leaf is very different from extract. 10x, 20x, 40x extracts are dramatically more potent. If using extract, start with a tiny amount (25-50mg of 10x). Many bad experiences come from using extract doses appropriate for plain leaf.
Sit or lie down before smoking salvia. Never stand. Use a water pipe to cool the smoke, as salvinorin A requires high temperature to vaporize and the smoke is harsh.
Most people who have negative experiences with salvia used too much, too fast, in an inappropriate setting. A dark, quiet room with one sober sitter and a low dose of plain leaf is the recommended introduction.
Salvia trips can be terrifying. This is not a party drug and it does not produce euphoria in most people. The experience is frequently described as bizarre, confusing, and overwhelming. Do your research before trying it.
See Also
References (5)
- Salvia Vault - Erowid
Erowid vault containing dosage information, experience reports, chemistry, and general information on Salvia divinorum.
erowid - Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist — Roth BL, Baner K, Westkaemper R, et al. Proceedings of the National Academy of Sciences (2002)
Landmark paper identifying salvinorin A as the first known naturally occurring non-alkaloid kappa opioid receptor agonist.
paper - PubChem: Salvinorin A
PubChem compound page for Salvinorin A, the primary psychoactive constituent of Salvia divinorum.
pubchem - Salvia - TripSit Factsheet
TripSit factsheet with dosage ranges, duration, and harm reduction information for Salvia divinorum.
tripsit - Salvia divinorum - Wikipedia
Wikipedia article covering the botany, history, pharmacology, and legal status of Salvia divinorum.
wikipedia